Experts Rebutted In Pfizer's Celebrex Case
By Christine Caulfield · July 23, 2007, 12:00 AM EDT
A dispute has erupted over proposed testimony in the product liability litigation over pharmaceutical giant Pfizer Inc.'s anti-inflammatory drug Celebrex, with both sides calling on a judge to bar the experts'...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login